Cesarean Section; Complications, Wound, Infection (Following Delivery)
5
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Vaginal Microbiota and Post-cesarean SSI
Patient Reported Experiences and Outcomes Associated with Standard C-Section Wound Closure Versus STRATAFIX/DERMABOND PRINEO Wound Closure (CS-PREO)
The Use of Steri3X for Prevention of Post-operative Wound Infections in Cesarean Sections
The S-CARE Trial: Manual Treatment for C-sections Scars, a Pilot Study.
Comparison of Two Routes of Administration of a Multimodal Analgesic Protocol in Postoperative Cesarean Section